光学基因组图谱用于血液系统恶性肿瘤结构变异分析
本文综述光学基因组图谱(OGM)的技术原理,比较其与核型分析、荧光原位杂交(FISH)和染色体微阵列等标准检测手段的优劣,并总结OGM在急性髓系白血病、骨髓增生异常综合征和B细胞急性淋巴细胞白血病中的临床应用价值。
要点
- OGM可检测易位、倒位、缺失、重复等结构变异,将核型、FISH、染色体微阵列多项检测合并为一次检测
- 平行研究显示OGM比核型分析或FISH检出并解析更多异常
- OGM对拷贝数进行归一化,在非二倍体核型时可能存在困难
核心结论
- OGM能显著简化实验室流程,将常规核型、FISH和染色体微阵列多项检测合并为一次检测;平行研究显示其比核型分析或FISH检出并解析更多异常,但归一化拷贝数使其在非二倍体核型时可能存在困难。
- 本文总结OGM的技术原理、与标准检测手段相比的优缺点,并说明其可能如何改变多种血液系统恶性肿瘤的一线检测,包括急性髓系白血病、骨髓增生异常综合征和B细胞急性淋巴细胞白血病。
研究设计与样本
- 本文为Test of the Month综述,总结OGM技术原理、与标准检测手段的优劣比较及其在血液系统恶性肿瘤中的应用。
主要发现
- OGM可检测易位、倒位、缺失、重复等结构变异。
- OGM将常规核型、荧光原位杂交(FISH)和染色体微阵列多项检测合并为一次检测,简化实验室流程。
- 平行研究显示OGM比核型分析或FISH检出并解析更多异常。
- OGM对拷贝数进行归一化,在非二倍体核型时可能存在困难。
临床怎么用
- 本文说明OGM可能改变多种血液系统恶性肿瘤的一线检测,并总结其在急性髓系白血病、骨髓增生异常综合征和B细胞急性淋巴细胞白血病中的临床应用价值。
局限性
- OGM对拷贝数进行归一化,在非二倍体核型时可能存在困难。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Optical genome mapping (OGM) is a technology that is rapidly being adopted in clinical genetics laboratories for its ability to detect structural variation (e.g., translocations, inversions, deletions, duplications, etc.) and replace several concurrent standard of care techniques (karyotype, fluorescence in situ hybridization, and chromosomal microarray). OGM can dramatically simplify lab workflow by reducing multiple tests (conventional karyotype, fluorescence in situ hybridization [FISH], and chromosomal microarray) into one test. The superior ability to detect structural variation across the genome removes the need for reflex FISH studies, which can dramatically reduce cost and turnaround time per sample. Parallel studies of OGM versus standard of care testing have demonstrated it can detect and resolve more abnormalities than karyotyping or FISH. However, like many molecular tests that normalize copy number it can have difficulty with non-diploid karyotypes. This Test of the Month review will summarize how the technique works, review the strengths and weaknesses of OGM compared to standard of care techniques and illustrate how the technique is likely to change front line testing in many hematologic malignancies-including summarizing the clinical utility in acute myeloid leukemia, myelodysplastic syndromes, and B cell acute lymphoblastic leukemia.
引用
- Smith AC, Neveling K, Kanagal-Shamanna R, et al. Optical genome mapping for structural variation analysis in hematologic malignancies. Am J Hematol. 2022. PMID: 35560245. doi:10.1002/ajh.26587
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。